期刊文献+

用HPLC-MS/MS法同时测定Caco-2细胞单层转运介质中吗替麦考酚酯和麦考酚酸的浓度 被引量:2

Simultaneous determination of mycophenolate mofetil and mycophenolic acid in transport medium of Caco-2 cell monolayers by HPLC-MS/MS method
下载PDF
导出
摘要 目的:建立HPLC-MS/MS法同时测定Caco-2细胞单层转运介质中吗替麦考酚酯(mycophenolate mofetil,MMF)和麦考酚酸(mycophenolic acid,MPA)的浓度,用于药物转运实验研究。方法:采用Zorbax Eclipse XDB-C18色谱柱(50mm×2.1mm,3.5μm);流动相A相:甲醇(含0.05%甲酸),B相:水(含0.05%甲酸);梯度洗脱:0~3.60min,40%A,流速:0.3ml/min,3.61~7.00min,65%A,流速:0.6ml/min,7.01~10.00min,40%A,流速:0.6ml/min;柱温:30℃,以吲哚美辛为内标。质谱检测方式:多种反应监测(MRM),选择监测的离子为:m/z433.8→194.8(MMF),m/z319.1→191.0(MPA)和m/z356.0→312.1(吲哚美辛)。结果:MMF和MPA检测的线性范围均为0.01~20μmol/L,线性回归方程分别为MMF:As/Ai=-0.035 2+0.394 5 c(r=0.999 1);MPA:As/Ai=0.005 5+0.050 8 c(r=0.999 5)。低、中、高浓度(0.1、1.5、15μmol/L)MMF的回收率分别为(103.2±7.5)%、(97.3±3.1)%和(96.0±3.4)%,日内、日间RSD<7.27%;低、中、高浓度(0.1、1.5、15μmol/L)MPA的回收率分别为(106.9±1.0)%、(106.0±5.7)%和(108.4±3.2)%,日内、日间RSD<9.25%(n=5)。结论:本研究建立的测定方法简便、准确、灵敏度高,适用于MMF和MPA体外转运实验研究。 Objective: To establish a HPLC-MS/MS method for simultaneous determination of mycophenolate mofetil(MMF) and mycophenolic acid(MPA) in transport medium of Caco-2 cell monolayer.Methods: The separation was performed on a Zorbax Eclipse XDB-C18 column(50 mm×2.1 mm,3.5 μm) at the temperature of 30 ℃.The mobile phase consisted of phase A(methanol containing 0.05% formic acid) and phase B(water containing 0.05% formic acid).The gradient elution profile was 40%A at the flow rate of 0.3 ml/min within 0-3.60 min,65%A at the flow rate of 0.6 ml/min within 3.61-7.00 min,40%A at the flow rate of 0.6 ml/min within 7.01-10.00 min.Indomethacin was used as the internal standard.Mass spectrometry was performed in multiple reaction monitoring(MRM) mode,with m/z of MMF 433.8→194.8,m/z of MPA 319.1→191.0 and m/z of indomethacin 356.0→312.1,respectively.Results: Both MMF and MPA were in linearity within the range of 0.01-20 μmol/L.The linear regression equations of MMF and MPA were As/Ai=-0.035 2+0.394 5 c(r=0.999 1) and As/Ai=0.005 5+0.050 8 c(r=0.999 5),respectively.The average recoveries of low,middle and high concentrations(0.1、1.5、15 μmol/L) of MMF were(103.2±7.5)%,(97.3±3.1)% and(96.0±3.4)%,respectively,while the average recoveries of low,middle and high concentrations of MPA were(106.9±1.0)%,(106.0±5.7)% and(108.4±3.2)%,respectively.Conclusion: This method is simple,accurate,sensitive and suitable for analysis of MMF and MPA in in vitro transportation.
出处 《药学服务与研究》 CAS CSCD 2012年第6期423-426,共4页 Pharmaceutical Care and Research
关键词 吗替麦考酚酯 麦考酚酸 CACO-2细胞单层 色谱法 高效液相 质谱法 联用 mycophenolate mofetil mycophenolic acid Caco-2 cell monolayer chromatography high performance liquid mass spectrometry tandem
  • 相关文献

参考文献6

  • 1Allison A C,Eugui E M. Mechanisms of action of myeopheno- late mofetil in preventing acute and chronic allograft rejeetion [J]. Transplantation,2005,80 (2 Suppl) :S 181-S 190.
  • 2Ucpinar S D, Stavchansky S. Quantitative determination of saquinavir from Caeo-2 cell monolayers by HPLC-UV. High performance liquid chromatography[J]. Biomed Chromatogr, 2003,17(1):21-25.
  • 3Zhou S, Li Y, Kestell P, et al. Determination of thalidomide in transport buffer for Caco-2 cell monolayers by high-perform- ance liquid chromatography with ultraviolet detection [J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2003,785 (1) :165-173.
  • 4Wang Z, Hop C E, Leung K H,et al. Determination of in vitro permeability of drug candidates through a caco-2 cell monolayer by liquid chromatography/tandem mass speetrome- try[J]. J Mass Spectrom,2000,35 (1) :71-76.
  • 5Smalley J, Kadiyala P, Xin B, et al. Development of an on-line extraction turbulent flow chromatography tandem mass spec- trometry method for cassette analysis of Caeo-2 cell based hi-directional assay samples [J]. J Chromatogr B Analyt Teehnol Biomed Life Sci,2006,830(2) :270-277.
  • 6Hakala K S,Laitinen L,Kaukonen A M,et al. Development of LC/MS/MS methods for cocktail dosed Caco-2 samples using atmospheric pressure photoionization and electrospray ioniza- tion[J]. Anal Chem,2003,75 (21) :5969-5977.

同被引文献21

  • 1沙先谊,方晓玲,吴云娟.9-硝基喜树碱在Caco-2细胞模型中的体外摄取、转运及外排动力学[J].药学学报,2004,39(10):839-843. 被引量:21
  • 2焦正,张明,梁惠琪,郁韵秋,钟明康,陆伟跃.肾移植患者麦考酚酸的群体药动学研究[J].中国药学杂志,2007,42(1):57-61. 被引量:10
  • 3樊宏伟,朱余兵,于翠霞,肖大伟.麦考酚酸酯分散片在健康人体的药动学和生物等效性[J].中国新药与临床杂志,2007,26(3):180-183. 被引量:3
  • 4阳国平,谭鸿毅,刘畅,黄志军,向红,袁洪.吗替麦考酚酯胶囊在健康人体中的相对生物利用度[J].中国医院药学杂志,2007,27(4):476-479. 被引量:7
  • 5ALLISON A G, EUGUI E M. Mechanisms of action of mycophe- nolate mofetil in preventing acute and chronic allograft rejection [ J ]. Transplantation,2005,80 ( suppt 2) . 181-190.
  • 6STAATZ C E, TETT S E. Clinical pharmacokinetics and phar- macodynamics of mycophenolate in solid organ transplant recipi- ents[J]. Clin Pharmacokinet, 2007, 46(1 ) .13-58.
  • 7PAWINSKI T, DURLIK M, SZLASKA I, et al. Comparison of mycophenolic acid pharmacokineticparameters in kidney trans- plant patients within thefirst 3 months post-transplant[J]. J Clin Pharm Ther, 2006, 31 (1). 27-34. 83.
  • 8VAN HEST R M, MATHOT R A, VULTO A G, et al. Within- patient variability of mycophenolic acid exposure. Therapeutic drug monitoring from a clinical point of view [ J ]. Ther Drug Moult, 2006, 28(1).31-34.
  • 9YU Z C, ZHOU P J, XU D,et al. Investigation on pharmacoki- netics of mycophenolic acid in Chinese adult renal transplant pa- tients[ J]. Br J Clin Pharmacol, 2006, 62 (4) .446-452.
  • 10MICEEL M, JACQUES M, DJAMILA C E, et al. Correlation of mycophenolic acid pharmacokinetic parameters with side effects in kidney transplant patients treated withmycophenolate mofetil [J]. Clin Chem,2001;47(1) . 88-94.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部